Johnson & Johnson

Johnson & Johnson is the world’s largest health care company. It is also the highest paid drug company in the world. J&J remains at the top of the Big Pharma list of powerful corporations. It is well known for consumer products like Band-Aids, Johnson’s Baby Powder and Tylenol. Its drugs, devices and products have led to scandals and lawsuits.

Johnson & Johnson has built a health care empire. It includes prescription and over-the-counter drugs, orthopedic implants, surgical products and household products.

The most popular brands include Band-Aids, Tylenol and Johnson’s Baby Powder. Still, more than 90 percent of J&J’s revenue comes from prescription drugs and medical devices.

A Huffington Post investigation called J&J “America’s most admired lawbreaker.”

J&J has been at the center of scandals and government investigations. It has issued recalls of some of its drugs and devices.

Consumers harmed by J&J products are suing the company. They question the company’s motives and say it puts profits over people.

About Johnson & Johnson

Johnson & Johnson has over 125,000 employees spread across 60 countries. Its main headquarters is in New Brunswick, New Jersey.

J&J brought in more than $76 billion in 2017. It ranked No. 1 in annual revenue among its competitors.

Alex Gorsky is its CEO. He is the seventh CEO to head J&J.

Johnson & Johnson Headquarters
Johnson & Johnson Headquarters in New Brunswick, New Jersey

Johnson & Johnson History

Robert, James and Edward Johnson founded Johnson & Johnson in 1886 in New Brunswick, New Jersey. The company focused on bandages, sterile sutures and wound care.

The company also sold women’s health products. These included sanitary protection products. It also sold maternity kits with first-aid products to make childbirth safer.

J&J created the first commercial dressings applied by consumers. We know this product made in 1921 as Band-Aids.

Johnson & Johnson Subsidiaries

Johnson & Johnson is a parent company for over 250 subsidiaries. Together, the companies make up “the Johnson & Johnson family of companies.”

Johnson & Johnson Subsidiaries Include:
  • McNeil
  • Janssen
  • Cilag
  • LifeScan
  • Biosense Webster
  • DePuy
  • Ethicon
  • Actelion
  • J&J Vision Care (Acuvue)
  • Animas Corporation (OneTouch)
  • Advanced Sterilization Products (ASP)
  • Acclarent
  • J&J Holdings
  • Neutrogena
  • Ortho
  • Synthes

Johnson & Johnson products fall into three categories. These include consumer health care products, medical devices and pharmaceutical drugs.

Popular J&J Products and Brands
Invokana
sodium-glucose cotransporter 2 (SGLT2) inhibitor to treat Type 2 diabetes
Tylenol
pain reliever
Levaquin
fluoroquinolone antibiotic
Risperdal
antipsychotic drug
Topamax
medication used to prevent seizures and migraines
Xarelto
blood thinner
Concerta
ADHD drug
Johnson's Baby Powder
personal care product that contains talc
Power Morcellators
device used to remove fibroids
Transvaginal Mesh
net-like implant for treating pelvic organ prolapse and stress urinary incontinence
Hip Replacement
artificial joint
Knee Replacement
artificial implant

Notable Johnson & Johnson Recalls

Johnson & Johnson recalled some of its most popular products after patients reported injuries. The FDA and other government agencies investigated.

Notable J&J Recalls
  • 1982 - McNeil

    Product Recalled - Tylenol (acetaminophen) capsules

    Reason for Recall - Medicine laced with potassium cyanide (poison) resulting in several patient deaths

  • 2009 to 2011 - McNeil

    Product Recalled - Several OTC medicines including Tylenol, Motrin, Benadryl, St. Joseph aspirin, Sudafed, Pepcid, Mylanta, Rolaids, Zyrtec, Zyrtec Eye Drops (tens of millions of bottles)

    Reason for Recall - Unpleasant smells causing nausea; tiny metal shards in liquid medicines; wrong ingredient levels

  • 2010 - DePuy [Pinnacle Systems]

    Product Recalled - ASR Hip Resurfacing System and ASR XL Acetabular System (metal-on-metal hip implants)

    Reason for Recall - Metal poisoning (metallosis); loosening of the implant or joint dislocation; additional surgeries

  • 2012 - Ethicon

    Product Recalled - Gynecare Prolift Kit, Gynecare Prolift+M Kit, Gynecare TVT Secure and Gynecare Prosima Pelvic Floor Repair System Kit (transvaginal mesh implants)

    Reason for Recall - Perforation of organs; vaginal bleeding and scarring; mesh erosion; severe pain

  • 2013 - McNeil

    Product Recalled - Motrin (ibuprofen) for infants (200,000 liquid bottles)

    Reason for Recall - May contain tiny particles of plastic

  • 2013 - Janssen

    Product Recalled - Risperdal Consta (injectable antipsychotic drug) (one lot)

    Reason for Recall - Routine testing showed evidence of mold

  • 2014 - Ethicon

    Product Recalled - Power Morcellators

    Reason for Recall - Spread of uterine cancer; rapid progression of the disease; death

  • 2016 - Ethicon

    Product Recalled - Physiomesh flexible composite hernia mesh

    Reason for Recall - Studies showed higher revision rates after implant

  • 2017 - SterilMed

    Product Recalled - Agilis Steerable Introducer Sheath (hemostatic heart valve)

    Reason for Recall - Device failure due to an improper seal of the sheath hub, which can allow blood leakage, device detachment during the procedure or development of an air embolism

Johnson & Johnson Lawsuits

J&J faced more than 100,000 lawsuits in March 2018 over claims its products are defective.

Lawsuits point to internal documents showing J&J and its subsidiaries knew about problems with their products but sold them anyway.

Pending Lawsuits Against J&J
DePuy ASR XL Acetabular System and DePuy ASR Hip Resurfacing System

Number of Lawsuits - More than 1,650

Injuries - dislocation, loosening, metallosis (metal poisoning), revision surgeries

Pinnacle Acetabular Cup

Number of Lawsuits - More than 9,400

Injuries - dislocation, loosening, metallosis (metal poisoning), revision surgeries

Pelvic (Transvaginal) Mesh

Number of Lawsuits - More than 24,000

Injuries - erosion, infection, pain, urinary problems, recurring prolapse, recurring incontinence

Risperdal

Number of Lawsuits - 18,500

Injuries - enlargement of male breasts (gynecomastia), surgery to remove male breasts, emotional injuries, diminished quality of life

Xarelto

Number of Lawsuits - More than 20,300

Injuries - severe, sometimes deadly bleeding events, blood clots, wound leaks, infection

Johnson’s Talcum Powder

Number of Lawsuits - More than 6,550

Injuries - ovarian cancer, mesothelioma cancer

Opioids (Duragesic, Nucynta and Nucynta ER)

Number of Lawsuits - More than 430

Injuries - addiction, overdose, respiratory depression, respiratory failure, death

Diagnosed with ovarian cancer or mesothelioma after talcum powder use? Get a Free Case Review

Major Johnson & Johnson Verdicts and Settlements

J&J was involved in seven of 2017’s top ten health-care-related verdicts.

The company was also involved in the third-largest pharmaceutical settlement with the U.S. Department of Justice. In 2013, J&J paid the Justice Department more than $2.2 billion. The settlement resolved civil and criminal allegations involving Risperdal, Invega and Natrecor.

Recent J&J Verdicts and Settlements
  • February 2016
    A jury in Missouri ordered J&J to pay $72 million in a Johnson’s Baby Powder case. An appeals court tossed the verdict in 2017.
  • March 2016
    A jury in Texas awarded five patients $500 million in a Pinnacle hip implant case. State law required the award be cut to $150 million.
  • December 2016
    A jury awarded $1 billion to six patients in a Pinnacle hip implant case. A judge slashed the award to $543 million.
  • April 2017
    A jury in Philadelphia ordered J&J to pay $20 million in a transvaginal mesh lawsuit.
  • May 2017
    A jury in Missouri awarded $110.5 million to a woman who developed ovarian cancer after using Johnson’s Baby Powder and Shower to Shower talcum powder. J&J planned to appeal the verdict.
  • May 2017
    J&J paid $33 million to most U.S. states and the District of Columbia. The states charged J&J with misrepresenting the manufacturing practices behind certain drugs. This included its Motrin products. These products were later recalled.
  • August 2017
    A California jury ordered J&J to pay $417 million in a Johnson’s Baby Powder and talcum powder case. A trial judge overturned the verdict in October 2017 and ordered a new trial.
  • November 2017
    A federal jury in Dallas ordered J&J to pay six patients $247 million in a Pinnacle hip implant case. J&J said it planned to appeal the verdict.
  • December 2017
    A federal jury in Philadelphia ordered J&J to pay $27.8 million in a Xarelto bleeding lawsuit. A judge overturned the verdict in 2018.
  • December 2017
    A New Jersey federal jury issued a verdict of $15 million against J&J in a Prolift pelvic mesh case.
  • March 2018
    An Indiana jury awarded a woman $35 million in a Prolift pelvic mesh case. J&J planned to appeal the verdict.

Please seek the advice of a medical professional before making health care decisions.

Kristin Compton
Written By Kristin Compton Writer

Kristin Compton's background is in legal studies. She worked as a paralegal before joining Drugwatch as a writer and researcher. She was also a member of the National Association of Legal Assistants. A mother and longtime patient, she has firsthand experience of the harmful effects prescription drugs can have on women and their children. Some of her qualifications include:

  • Bachelor of Arts in Legal Studies | Pre-Law from University of West Florida
  • Past employment with The Health Law Firm and Kerrigan, Estess, Rankin, McLeod & Thompson LLC
  • Personal experience battling severe food allergies, asthma and high-risk pregnancies
Edited By

33 Cited Research Articles

  1. U.S. Judicial Panel on Multidistrict Litigation. (2018, February 15). MDL Statistics Report – Distribution of Pending MDL Dockets by District. Retrieved from http://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-February-15-2018.pdf
  2. Johnson & Johnson. (2017, April 30). 130 Years of Healthcare Innovation at Johnson & Johnson. Our Heritage. Retrieved from https://www.jnj.com/latest-news/130-years-of-healthcare-innovation-at-johnson-and-johnson-our-story-museum
  3. Blake, H. (2013, June 26). A history of Johnson & Johnson. Pharmaphorum. Retrieved from https://pharmaphorum.com/articles/a-history-of-johnson-johnson/
  4. Johnson & Johnson. (n.d.). About Johnson & Johnson. Retrieved from https://www.jnj.com/about-jnj
  5. Johnson & Johnson. (2017, March). 2016 Annual Report. Retrieved from https://jnj.brightspotcdn.com/88/3f/b666368546bcab9fd520594a6016/2017-0310-ar-bookmarked.pdf
  6. Gibbs, C. (2017, August 22). $417 million awarded to woman in baby powder ovarian cancer suit. Daily News. Retrieved from http://www.nydailynews.com/life-style/health/417-million-awarded-woman-baby-powder-ovarian-cancer-suit-article-1.3432769
  7. Bellon, T. (2017, November 16). Johnson & Johnson hit with $247 million verdict in hip implant trial. Reuters. Retrieved from https://www.reuters.com/article/us-johnson-johnson-verdict/johnson-johnson-hit-with-247-million-verdict-in-hip-implant-trial-idUSKBN1DG2MB
  8. Market Watch. (2018, March 12). Annual Financials for Johnson & Johnson. Retrieved from https://www.marketwatch.com/investing/stock/jnj/financials
  9. Associated Press. (2017, May 5). Johnson & Johnson Hit With $110 Million Verdict in Baby Powder Cancer Suit. NBC News. Retrieved from https://www.nbcnews.com/health/cancer/johnson-johnson-hit-110-million-verdict-baby-powder-cancer-suit-n755366
  10. Raymond, N. & Bellon, T. (2018, January 9). Bayer, J&J win reversal of $28 million verdict in Xarelto lawsuit. Reuters. Retrieved from https://www.reuters.com/article/us-bayer-xarelto/bayer-jj-win-reversal-of-28-million-verdict-in-xarelto-lawsuit-idUSKBN1EZ08M
  11. Cowen, R. (2017, December 14). Jury awards $15 million in damages in pelvic mesh case. NorthJersey.com USA Today Network. Retrieved from https://www.northjersey.com/story/news/health/2017/12/14/pelvic-mesh-jury-awards-15-million-damages/953278001/
  12. Johnson & Johnson. (n.d.). Products. Retrieved from https://www.jnj.com/healthcare-products?utm_source=bing&utm_medium=cpc&utm_campaign=Phrase+-+J%26J+Branded+-+General&utm_content=J%26J+-+General+-+P&utm_term=%22johnson+and+johnson%22&gclid=CNmqvqO85dkCFSaXxQIdIRML-Q&gclsrc=ds
  13. U.S. Food and Drug Administration. (2018, January 2). Sterilmed Reprocessed Agilis Steerable Introducer Sheath recalled due to improper seal of the sheath hub. U.S. Department of Health and Human Services. Retrieved from https://www.fda.gov/MedicalDevices/Safety/ListofRecalls/ucm590903.htm
  14. Thomas, K. (2013, September 12). New Recalls by Johnson & Johnson Raise Concern About Quality Control Improvements. The New York Times. Retrieved from http://www.nytimes.com/2013/09/13/business/new-recalls-by-johnson-johnson-raise-concern-about-quality-control-improvements.html
  15. Johnson, L. A. (2017, May 24). Drugmaker Paying $33M Over Recalled Nonprescription Meds. U.S. News & World Report. Retrieved from https://www.usnews.com/news/us/articles/2017-05-24/drugmaker-paying-33m-over-recalled-nonprescription-meds
  16. Johnson & Johnson. (2013, January 22). Johnson & Johnson 2012 fourth-quarter and full-year results. Retrieved from http://www.investor.jnj.com/releasedetail.cfm?ReleaseID=734718
  17. Johnson & Johnson. (2012, January 1). Subsidiaries. Retrieved from http://files.shareholder.com/downloads/JNJ/0x0x564066/6b60fc92-8ac9-4933-82a4-f4a1579b6f01/2012_10-K_Exhibit_21.pdf
  18. Saul, S. (2006, June 27). Johnson & Johnson buys Pfizer unit for $16.6 billion. The New York Times. Retrieved from http://www.nytimes.com/2006/06/27/business/27johnson.html?_r=0
  19. Johnson & Johnson. (2012, January 23). Johnson & Johnson reports 2011 fourth-quarter and full-year results. Retrieved from http://www.jnj.com/news/all/johnson-and-johnson-reports-2011-fourth-quarter-and-full-year-results
  20. Fisk, M. & Voreacos, D. (2012, August 30). J&J will pay $181 million to settle Risperdal ad claims. Bloomberg. Retrieved from http://www.bloomberg.com/news/2012-08-30/j-j-will-pay-181-million-to-settle-risperdal-ad-claims.html
  21. Feeley, J. & Voreacos, D. (2013, January 23). J&J predicted 37% hip-failure rate. Bloomberg. Retrieved from http://www.bloomberg.com/news/2013-01-23/j-j-study-showed-37-percent-hip-failure-rate-records-found.html
  22. Johnson & Johnson. (2011, October 18). The Wall Street Journal. Retrieved from http://www.marketwatch.com/investing/stock/jnj/profile
  23. Profile: Johnson & Johnson. (2013, January 23). Reuters. Retrieved from http://www.reuters.com/finance/stocks/companyProfile?symbol=JNJ.N
  24. Rockoff, J. (2013, January 23). When J&J learned of implant problems. The Wall Street Journal.
  25. Abelson, R. & Singer, N. (2011, January 15). Can Johnson & Johnson get its act together? The New York Times. Retrieved from http://www.nytimes.com/2011/01/16/business/16johnson-and-johnson.html?pagewanted=all
  26. Janssen Global Services. (2013, January 24). The Dr. Paul Janssen Award. Retrieved from http://www.pauljanssenaward.com/
  27. Brill, S. (2015). America’s Most Admired Lawbreaker. Huffington Post Highline. Retrieved from: http://highline.huffingtonpost.com/miracleindustry/americas-most-admired-lawbreaker/
  28. Levitz, J. (2015, May 27). FBI is investigating hysterectomy device found to spread uterine cancer. The Wall Street Journal. Retrieved from: http://www.wsj.com/articles/fbi-is-investigating-surgical-device-1432746641
  29. Schneider, M. (2014, April 30). Johnson & Johnson halts power morcellator sales, for now. Ob.Gyn. News. Retrieved from: http://www.obgynnews.com/single-view/johnson-johnson-halts-power-morcellator-sales-for-now/2caa672cefc24d81f83d3734a07f5bc3.html
  30. U.S. Food and Drug Administration. (2014, November 25). Immediately in effect guidance document: Product labeling for laparoscopic power morcellators. Retrieved from http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM424123.pdf
  31. Cefalu, W.T. & Riddle, M.C. (2015). SGLT2 Inhibitors: The Latest “New Kids on the Block”! Diabetes Care. Retrieved from http://care.diabetesjournals.org/content/38/3/352.full
  32. U.S. Food and Drug Administration. (2015, August 28). FDA drug safety communication: FDA warns that DPP-4 inhibitors for type 2 diabetes may cause severe joint pain. Retrieved from http://www.fda.gov/Drugs/DrugSafety/ucm459579.htm
  33. Ramsey, L. (2017, May 17). The world's largest drugmaker thinks it has 11 billion-dollar drugs in the pipeline — here's what they treat. Retrieved from http://www.businessinsider.com/johnson-and-johnson-blockbuster-drug-potentials-by-2021-2017-5
View All Sources
Who Am I Calling?

Calling this number connects you with Wilson and Peterson, LLP or one of its trusted legal partners. A law firm representative will review your case for free.

Wilson and Peterson, LLP funds Drugwatch because it supports the organization’s mission to keep people safe from dangerous drugs and medical devices.

(888) 645-1617